TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TransMedics (NASDAQ ... Transporters use oxygenated perfusion at low temperatures, however, do not fully mimic physiological conditions. The TransMedics Organ Care System, OCS is a revolutionary ...

BURLINGAME, CA, UNITED STATES, January 14, 2025 /EINPresswire / -- The Perfusion System Market Report is the result of extensive research and analysis conducted by our team of experienced market ...

Additionally, as TransMedics plans to enter the dynamic cold perfusion market in the second half of 2025, it may face more direct competition from established players like XVIVO. This increased ...